Results 131 to 140 of about 9,546,528 (270)
Plasma‐based detection of actionable mutations is a promising approach in lung cancer management. Analysis of ctDNA with a multigene NGS panel identified TP53, KRAS, and EGFR as the most frequently altered, with TP53 and KRAS in treatment‐naïve patients and TP53 and EGFR in previously treated patients.
Giovanna Maria Stanfoca Casagrande +11 more
wiley +1 more source
Workshop @ deRSE19: Libraries for Research Software & Engineers
Ronny Gey +4 more
doaj +1 more source
Aggressive prostate cancer is associated with pericyte dysfunction
Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero +11 more
wiley +1 more source
Introducing the FAIR Principles for research software. [PDF]
Barker M +10 more
europepmc +1 more source
Mötesplats Rydberg abstract:Software is fundamental to research and it is far more important than anybody knows. From short, thrown-together temporary scripts, through an abundance of complex spreadsheets analysing collected data, to millions of lines of code behind international efforts such as the Large Hadron Collider and the Square Kilometre Array,
openaire +1 more source
Research Software Sustainability
a talk about software sustainability given as a guest lecture in LaTech CSC 532: Advanced Topics: Software ...
openaire +1 more source
ERRFI1, a neural crest (NC)‐associated gene, was upregulated in melanoma and negatively correlated with the expression of melanocytic differentiation markers and the susceptibility of melanoma cells toward BRAF inhibitors (BRAFi). Knocking down ERRFI1 significantly increased the sensitivity of melanoma cells to BRAFi.
Nina Wang +8 more
wiley +1 more source
Making Biomedical Research Software FAIR: Actionable Step-by-step Guidelines with a User-support Tool. [PDF]
Patel B +3 more
europepmc +1 more source
Detection of extrachromosomal circular DNA (eccDNA) in plasma samples from EGFR‐mutated non‐small cell lung cancer patients. Plasma was collected before and during treatment with the EGFR‐tyrosine kinase inhibitor osimertinib. Plasma eccDNA was detected in all cancer samples, and the presence of the EGFR gene on eccDNA serves as a potential biomarker ...
Simone Stensgaard +5 more
wiley +1 more source
Documenting research software in engineering science. [PDF]
Hermann S, Fehr J.
europepmc +1 more source

